-
Je něco špatně v tomto záznamu ?
Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats
J. Klimas, M. Olvedy, K. Ochodnicka-Mackovicova, P. Kruzliak, S. Cacanyiova, F. Kristek, P. Krenek, P. Ochodnicky,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2012
Free Medical Journals
od 2000
PubMed Central
od 2000
Europe PubMed Central
od 2000 do 2020
ProQuest Central
od 2000-07-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2012-01-01
Medline Complete (EBSCOhost)
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-07-01
Wiley Free Content
od 2000
Wiley-Blackwell Open Access Titles
od 2000
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
25766467
DOI
10.1111/jcmm.12573
Knihovny.cz E-zdroje
- MeSH
- angiotensin konvertující enzym metabolismus MeSH
- hypertenze komplikace farmakoterapie genetika prevence a kontrola MeSH
- hypertrofie levé komory srdeční komplikace farmakoterapie genetika prevence a kontrola MeSH
- ledviny účinky léků enzymologie MeSH
- losartan aplikace a dávkování farmakologie terapeutické užití MeSH
- messenger RNA genetika metabolismus MeSH
- myokard enzymologie MeSH
- novorozená zvířata MeSH
- oxid dusnatý metabolismus MeSH
- potkani inbrední SHR MeSH
- protoonkogenní proteiny metabolismus MeSH
- receptory spřažené s G-proteiny metabolismus MeSH
- regulace genové exprese účinky léků MeSH
- renin-angiotensin systém účinky léků genetika MeSH
- signální transdukce účinky léků MeSH
- srdeční komory účinky léků metabolismus patologie MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Since the identification of the alternative angiotensin converting enzyme (ACE)2/Ang-(1-7)/Mas receptor axis, renin-angiotensin system (RAS) is a new complex target for a pharmacological intervention. We investigated the expression of RAS components in the heart and kidney during the development of hypertension and its perinatal treatment with losartan in young spontaneously hypertensive rats (SHR). Expressions of RAS genes were studied by the RT-PCR in the left ventricle and kidney of rats: normotensive Wistar, untreated SHR, SHR treated with losartan since perinatal period until week 9 of age (20 mg/kg/day) and SHR treated with losartan only until week 4 of age and discontinued until week 9. In the hypertrophied left ventricle of SHR, cardiac expressions of Ace and Mas were decreased while those of AT1 receptor (Agtr1a) and Ace2 were unchanged. Continuous losartan administration reduced LV weight (0.43 ± 0.02; P < 0.05 versus SHR) but did not influence altered cardiac RAS expression. Increased blood pressure in SHR (149 ± 2 in SHR versus 109 ± 2 mmHg in Wistar; P < 0.05) was associated with a lower renal expressions of renin, Agtr1a and Mas and with an increase in ACE2. Continuous losartan administration lowered blood pressure to control levels (105 ± 3 mmHg; P < 0.05 versus SHR), however, only renal renin and ACE2 were significantly up-regulated (for both P < 0.05 versus SHR). Conclusively, prevention of hypertension and LV hypertrophy development by losartan was unrelated to cardiac or renal expression of Mas. Increased renal Ace2, and its further increase by losartan suggests the influence of locally generated Ang-(1-7) in organ response to the developing hypertension in SHRs.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010463
- 003
- CZ-PrNML
- 005
- 20160414121428.0
- 007
- ta
- 008
- 160408s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jcmm.12573 $2 doi
- 024 7_
- $a 10.1111/jcmm.12573 $2 doi
- 035 __
- $a (PubMed)25766467
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Klimas, Jan $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.
- 245 10
- $a Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats / $c J. Klimas, M. Olvedy, K. Ochodnicka-Mackovicova, P. Kruzliak, S. Cacanyiova, F. Kristek, P. Krenek, P. Ochodnicky,
- 520 9_
- $a Since the identification of the alternative angiotensin converting enzyme (ACE)2/Ang-(1-7)/Mas receptor axis, renin-angiotensin system (RAS) is a new complex target for a pharmacological intervention. We investigated the expression of RAS components in the heart and kidney during the development of hypertension and its perinatal treatment with losartan in young spontaneously hypertensive rats (SHR). Expressions of RAS genes were studied by the RT-PCR in the left ventricle and kidney of rats: normotensive Wistar, untreated SHR, SHR treated with losartan since perinatal period until week 9 of age (20 mg/kg/day) and SHR treated with losartan only until week 4 of age and discontinued until week 9. In the hypertrophied left ventricle of SHR, cardiac expressions of Ace and Mas were decreased while those of AT1 receptor (Agtr1a) and Ace2 were unchanged. Continuous losartan administration reduced LV weight (0.43 ± 0.02; P < 0.05 versus SHR) but did not influence altered cardiac RAS expression. Increased blood pressure in SHR (149 ± 2 in SHR versus 109 ± 2 mmHg in Wistar; P < 0.05) was associated with a lower renal expressions of renin, Agtr1a and Mas and with an increase in ACE2. Continuous losartan administration lowered blood pressure to control levels (105 ± 3 mmHg; P < 0.05 versus SHR), however, only renal renin and ACE2 were significantly up-regulated (for both P < 0.05 versus SHR). Conclusively, prevention of hypertension and LV hypertrophy development by losartan was unrelated to cardiac or renal expression of Mas. Increased renal Ace2, and its further increase by losartan suggests the influence of locally generated Ang-(1-7) in organ response to the developing hypertension in SHRs.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a novorozená zvířata $7 D000831
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a regulace genové exprese $x účinky léků $7 D005786
- 650 _2
- $a srdeční komory $x účinky léků $x metabolismus $x patologie $7 D006352
- 650 _2
- $a hypertenze $x komplikace $x farmakoterapie $x genetika $x prevence a kontrola $7 D006973
- 650 _2
- $a hypertrofie levé komory srdeční $x komplikace $x farmakoterapie $x genetika $x prevence a kontrola $7 D017379
- 650 _2
- $a ledviny $x účinky léků $x enzymologie $7 D007668
- 650 _2
- $a losartan $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D019808
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myokard $x enzymologie $7 D009206
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a angiotensin konvertující enzym $x metabolismus $7 D007703
- 650 _2
- $a protoonkogenní proteiny $x metabolismus $7 D011518
- 650 _2
- $a messenger RNA $x genetika $x metabolismus $7 D012333
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a receptory spřažené s G-proteiny $x metabolismus $7 D043562
- 650 _2
- $a renin-angiotensin systém $x účinky léků $x genetika $7 D012084
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Olvedy, Michael $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.
- 700 1_
- $a Ochodnicka-Mackovicova, Katarina $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.
- 700 1_
- $a Kruzliak, Peter $u Department of Cardiovascular Diseases, International Clinical Research Centre, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Cacanyiova, Sona $u Institute of Normal and Pathological Physiology, Centre of Excellence for Cardiovascular Research, Slovak Academy of Sciences, Bratislava, Slovakia.
- 700 1_
- $a Kristek, Frantisek $u Institute of Normal and Pathological Physiology, Centre of Excellence for Cardiovascular Research, Slovak Academy of Sciences, Bratislava, Slovakia.
- 700 1_
- $a Krenek, Peter $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.
- 700 1_
- $a Ochodnicky, Peter $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.
- 773 0_
- $w MED00006785 $t Journal of cellular and molecular medicine $x 1582-4934 $g Roč. 19, č. 8 (2015), s. 1965-74
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25766467 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20160414121513 $b ABA008
- 999 __
- $a ok $b bmc $g 1113892 $s 934831
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 19 $c 8 $d 1965-74 $e 20150312 $i 1582-4934 $m Journal of cellular and molecular medicine $n J Cell Mol Med $x MED00006785
- LZP __
- $a Pubmed-20160408